|
 |
Naturalism > Efficacy
The following information is about Efficacy.
Efficacy Defined
The power to produce an effect
This definition is in context to Naturalism. See more contextual defintions for Efficacy.
Is Damascus planning a return to Lebanon?
Published October 6, 2008, 12:54 pm, The Daily Star Lebannon
While Lebanon probably need not fear an impending incursion by the almost 10,000 Syrian troops on Lebanon's northern border, the recent Syrian deployment has nothing to do with the stated aim of deterring smuggling and instead puts the international community on notice that Syria considers restive North Lebanon a threat to Syrian security.
New Stanford diagnostic test for rare leukemia appears to give faster results, study finds
Published October 6, 2008, 11:02 am, PhysOrg
A new twist on a well-known cell sorting technique may allow physicians to diagnose rare leukemias in hours instead of weeks, according to a study by researchers at the Stanford University School of Medicine and UC-San Francisco. The clinical promise of the Stanford-developed approach, which eavesdrops on individual cells to decipher potentially dangerous molecular conversations, is likely to ...
New Test Detects Rare Leukemia More Quickly
Published October 6, 2008, 10:49 am, ABC 7 El Paso
MONDAY, Oct. 6 (HealthDay News) -- A new technique may help doctors diagnose a rare form of leukemia in a matter of hours instead of weeks, researchers say.
New Stanford diagnostic test for rare leukemia appears to give faster results, study finds
Published October 6, 2008, 9:31 am, EurekAlert!
( Stanford University Medical Center ) A new twist on a well-known cell sorting technique may allow physicians to diagnose rare leukemias in hours instead of weeks, according to a study by researchers at the Stanford University School of Medicine and UC-San Francisco. The clinical promise of the Stanford-developed approach, which eavesdrops on individual cells to decipher potentially dangerous ...
New Stanford Diagnostic Test for Rare Leukemia Appears to Give Faster Results, Study Finds
Published October 6, 2008, 9:00 am, Business Wire via Yahoo! Finance
STANFORD, Calif.----A new twist on a well-known cell sorting technique may allow physicians to diagnose rare leukemias in hours instead of weeks, according to a study by researchers at the Stanford University School of Medicine and UC-San Francisco.
Learn about the Global Clinical Trial Business Report and Analysis 2008-2018
Published October 6, 2008, 7:33 am, Marketwire via Yahoo! Finance
Reportlinker.com announces that a new market research report related to the Pharmaceutical industry is available in its catalogue.
Genta Updates Progress of its Phase 3 Trial of Genasense(R) in Patients with Advanced Melanoma
Published October 6, 2008, 5:05 am, Business Wire via Yahoo! Finance
BERKELEY HEIGHTS, N.J.----Genta Incorporated announced the presentation of a progress update from the Company's ongoing Phase 3 trial of Genasense® Injection, Genta's lead oncology product, in patients with advanced melanoma.
CombinatoRx Announces Top-Line Results from Phase 2b Study of Synavive(TM) (CRx-102) for Knee Osteoarthritis
Published October 6, 2008, 4:56 am, Centre Daily Times
CombinatoRx, Incorporated (NASDAQ: CRXX), today announced preliminary top-line results from COMET-1 (CRx-102 Osteoarthritis Multi-center Evaluation Trial), the Company's Phase 2b clinical trial designed to evaluate the safety and efficacy of Synavive (CRx-102) in subjects with symptomatic knee osteoarthritis (OA). While there was a trend in favor of Synavive, and an observed dose-response ...
CombinatoRx Announces Top-Line Results from Phase 2b Study of Synavive(TM) (CRx-102) for Knee Osteoarthritis
Published October 6, 2008, 4:30 am, Business Wire via Yahoo! Finance
CAMBRIDGE, Mass.----CombinatoRx, Incorporated , today announced preliminary top-line results from COMET-1 , the Company's Phase 2b clinical trial designed to evaluate the safety and efficacy of Synavive in subjects with symptomatic knee osteoarthritis .
Progenics Announces Progress And Presentations In HIV Therapy Program - Enrollment For PRO 140 Phase 2 Clinical ...
Published October 6, 2008, 4:07 am, Medical News Today
Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) today announced the completion of enrollment in two, phase 2 clinical studies of PRO 140, an investigational drug that is being developed for treatment of human immunodeficiency virus (HIV) infection. The phase 2 studies are separately evaluating intravenous and subcutaneous forms of PRO 140.
Are you looking for additional Naturalism > Efficacy news? Try our new "Efficacy News Focus" area.
Off-site Efficacy Links, User Submitted
The following links have been collected through user bookmark submission in the Efficacy category. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.
Sat Oct 4
Thu Oct 2
- 23 Personal Tools to Learn More About Yourself | FlowingData
- International Conference on Harmonization (ICH) - Efficacy
Fri Sep 26
Tue Sep 16
Mon Sep 15
If you would like to find additional social bookmark based links on the topic of we recommend the Open Tag Directory > Efficacy. If you would like to find related tags we recommend Tag Patterns > Efficacy
Off-site Efficacy Research Links
If you still need additional information on Efficacy then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.
Naturalism Topics
Everything you need to know about Naturalism
Naturalism
If you know the Naturalism Term Name use the links below to quickly jump to your desired focus.
Bookmark Us
The On Topic Network
This website is part of The On Topic Network.
Thank You
Naturalism.On-Topic.net was developed by Odin Metatech, Inc and runs on the Odin Assemble platform.
Best Viewed With
License
This work is licensed under Creative Commons.